Efficacy of 300IR 5-grass pollen extract sublingual tablet in patients with grass pollen-associated allergic rhinoconjunctivitis assessed by daily combined score in a long term study

被引：0
作者：
Didier, A. [1 ]
Montagut, A. [2 ]
Zeldin, R. K. [2 ]
机构：
[1] Rangueil Larrey Hosp, Dept Resp Dis, Toulouse, France
[2] Stallergenes SA, Global Clin Dev, Antony, France
来源：
ALLERGY | 2014年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
1096
引用
收藏
页码：403 / 404
页数：2
相关论文
共 50 条
[41]   DISEASE-MODIFYING EFFECT OF 300IR 5-GRASS POLLEN SUBLINGUAL TABLETS IN THE TREATMENT OF GRASS POLLEN-INDUCED ALLERGIC RHINOCONJUNCTIVITIS IN ADULTS: ASSESSMENT OVER AN ADDITIONAL IMMUNOTHERAPY-FREE POLLEN SEASON [J].
Didier, A. ;
Melac, M. ;
Soulie, S. ;
Furrer, M. P. ;
Zeldin, R. K. .
RESPIROLOGY, 2012, 17 :53-53
[42]   A Us Study Of 5-grass Pollen Allergen Extract In Adults With Grass Pollen-induced Allergic Rhinoconjunctivitis - Results Of Secondary Efficacy Assessments [J].
Cox, L. ;
Casale, T. B. ;
Nayak, A. ;
Creticos, P. ;
Montagut, A. ;
Zeldin, R. K. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) :AB46-AB46
[43]   Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis [J].
Malling, H-J. ;
Montagut, A. ;
Melac, M. ;
Patriarca, G. ;
Panzner, P. ;
Seberova, E. ;
Didier, A. .
CLINICAL AND EXPERIMENTAL ALLERGY, 2009, 39 (03) :387-393
[44]   Consistency Of Clinical Results Throughout Short-term And Long-term Studies With Sublingual 300IR 5-grass Pollen Tablets [J].
Bachert, C. ;
Didier, A. ;
Wahn, H. ;
Le Gall, M. ;
De Beaumont, O. ;
Melac, M. ;
Montagut, A. ;
Malling, H. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) :AB49-AB49
[45]   Clinical efficacy of 300IR 5-grass pollen extract sublingual tablet by sensitisation status: pooled data analysis from four natural field clinical studies [J].
Zeldin, R. K. ;
Amistani, Y. ;
Furrer, M-P ;
Melac, M. .
ALLERGY, 2013, 68 :551-551
[46]   Treatment satisfaction during sublingual immunotherapy with a 5-grass pollen tablet for allergic rhinoconjunctivitis: a prospective, non-interventional study [J].
Hadler, M. ;
Karagiannis, E. .
ALLERGY, 2015, 70 :258-259
[47]   Sustained Efficacy and Safety Of a Pre-coseasonal 300IR 5-grass Pollen SLIT Tablet Over 3 Pollen Seasons In Adult SAR [J].
Didier, A. ;
Worm, M. ;
Horak, F. ;
Melac, M. ;
De Beaumont, O. ;
Le Gall, M. ;
Montagut, A. ;
Galvain, S. ;
Malling, H. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) :AB151-AB151
[48]   Design and objectives of ALTO: a 5-year observational study evaluating the quality of life of allergic rhino-conjunctivitis patients treated by 300IR 5-grass pollen sublingual tablet [J].
Didier, A. ;
Bousquet, P-J ;
Davila, I ;
Pfaar, O. ;
Robin, B. .
ALLERGY, 2014, 69 :611-611
[49]   Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis [J].
Didier, Alain ;
Malling, Hans-Jorgen ;
Worm, Margitta ;
Horak, Friedrich ;
Jaeger, Siegfried ;
Montagut, Armelle ;
Andre, Claude ;
de Beaumont, Olivier ;
Melac, Michel .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (06) :1338-1345
[50]   Impact of discontinuous administration of a 300IR sublingual tablet of five-grass-pollen extract on symptomatic treatment use [J].
Didier, A. ;
Malling, H. ;
Worm, M. ;
Soulie, S. ;
Abiteboul, K. ;
Zeldin, R. .
ALLERGY, 2012, 67 :415-415
12345